Rejuvenation biotech - progress and potential, with Karl Pfleger
London Futurists
00:00
Advancements in Aging Biotech
This chapter examines the rapid growth of the aging biotech sector, focusing on funding, clinical trials, and the challenges of developing effective therapies. It highlights the role of AI in expediting trial processes and discusses key areas of rejuvenation biotechnology such as senolytics and epigenetic reprogramming. The chapter also covers investment strategies and the expanding landscape of companies committed to combating age-related diseases.
Transcript
Play full episode
